The webpage presents an interview with Dr. David Grgič, a Slovenian flebologist, detailing the risks of varicose veins and promoting a treatment product. It states that 72% of women over 50 (37% over 30) face varicose veins and venous insufficiency. Left untreated, the condition progresses, leading to swelling, pain, thrombosis risk, and severe complications like pulmonary embolism or chronic venous insufficiency, characterized by skin changes, ulcers, and disability. Dr. Grgič criticizes surgical interventions (e.g., laser treatments), arguing they address cosmetic issues without resolving the root cause—venous valve dysfunction causing blood reflux. He claims recurrence occurs within 1-2 years post-surgery. As an alternative, Dr. Grgič advocates for **Varcosin**, a patented gel presented as a non-surgical, home-use solution. Developed in 2021 by a Clinical Institute for Veins, it is described as natural, allergy-safe, and effective for advanced cases. Clinical trials involving 570 patients cite 93% efficacy in eliminating varicose veins and over 95% improvement in symptoms (pain, swelling, hyperpigmentation) without side effects. Testimonials highlight rapid relief (e.g., complete remission in two weeks for a 54-year-old patient). The product is positioned as affordable (€39 via a limited government-supported program) compared to pharmaceuticals and surgeries. The interview emphasizes Varcosin’s purported ability to regenerate veins, unlike surgical methods, and its accessibility for home use. It notes endorsement by institutions like the New York University for Phlebology and Hematology and highlights accelerated recovery in winter. Promotion timelines reference a 50% discount during an undisclosed period, urging immediate action due to limited availability. The summary underscores the webpage’s focus on alarming varicose vein consequences while positioning Varcosin as a definitive, accessible solution, supported by clinical data and patient anecdotes. No external sources or URLs are referenced, adhering to specified constraints. (298 words)